聖マリアンナ医科大学 感染症講座

活動紹介

TOP > 活動紹介 > 2020年度業績

活動紹介

業績

  1. 國島広之. C. difficile感染での治療方針,新しい治療薬についても教えてください AST虎の巻:日常の疑問に答える! 2020;(1):61-67.
  2. 土田知也, 山崎行敬, 國島広之, 廣瀬雅宣, 藤谷茂樹, 松田隆秀. 新型コロナウイルス陽性患者の臨床経過自験6 例の肺炎像の有無とPCR 陰性化時期について. 感染症学雑誌, 2020;94(4)：514-519.
  3. 國島広之. 類鼻疽(メリオイドーシス). 臨床と微生物, 2020;47(3)：33-37.
  4. 高野知憲, 山﨑行敬, 國島広之. 訪日外国人の感染症治療におけるempiric therapy. 診断と治療, 2020;108(67)：887-891.
  5. 中谷佳子, 國島広之, 徳田浩一. ビュッフェスタイルレストランの汚染リスクとその対策～新型コロナウイルス感染症とともに生活するために～. 環境感染誌, 020;2(36)：89-91.
  6. 山﨑行敬, 高野知憲, 國島広之. 日本のCOVID-19診療の指針-これまでの経験から見えてきた診療の在り方. 感染と抗菌薬, 2021;24(1)：1-8.
  7. Alice Y. Guh, Preeta K. Kutty（監修：斎藤浩輝, 國島広之）. In the Clinic® Clostridioides difficile 感染症. Clostridioides difficile Infection (Japanese Version), 2021;：DOI-10.7326/IsTranslatedFrom_AITC201810020_Japanese.
  8. Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Shuhei Nomura, Keisuke Ejima, Shoi Shi, Akifumi Eguchi, Toshibumi Taniguchi, Haruka Sakamoto, Hiroyuki Kunishima, Stuart Gilmour, Hiroshi Nishiura, Hiroaki Miyata. Early SNS-based monitoring system for the COVID-19 outbreak in Japan: a population-level observational study. J-stage, 2020;：DOI-10.2188/jea.JE20200150.
  9. Toshinori Hara, Hiromichi Suzuki, Tadatomo Oyanagi, Norito Koyanagi, Akihito Ushiki, Naoki Kawabata, Miki Goto, Yukio Hida, Yuji Yaguchi, Kiyoko Tamai, Shigeyuki Notake, Yosuke Kawashima, Akio Sugiyama, Keiichi Uemura, Seiya Kashiyama, Toru Nanmoku, Satoshi Suzuki, Hiroshi Yamazaki, Hideki Kimura, Hiroyuki Kunishima, Hiroki Ohge. Clinical Evaluation of a Non-Purified Direct Molecular Assay for the Detection of Clostridioides Difficile Toxin Genes in Stool Specimens. PLOS ONE, 2020;：DOI-10.1371/journal.pone.0234119.
  10. Shuhei Nomura, Daisuke Yoneoka, Shoi Shi, Yuta Tanoue, Takayuki Kawashima, Akifumi Eguchi, Kentaro Matsuura, Koji Makiyama, Keisuke Ejima, Toshibumi Taniguchi, Haruka Sakamoto, Hiroyuki Kunishima, Stuart Gilmour,Hiroshi Nishiura, Hiroaki Miyata. An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?. The Lancet Regional Health - Western Pacific, 2020;：DOI-10.1016/j.lanwpc.2020.100011.
  11. Daisuke Yoneoka, Yuta Tanoue, Takayuki Kawashima, Shuhei Nomura, Shoi Shi, Akifumi Eguchi, Keisuke Ejima, Toshibumi Taniguchi, Haruka Sakamoto, Hiroyuki Kunishima, Stuart Gilmour, Hiroshi Nishiura, Hiroaki Miyata,. Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo. The Lancet Regional Health - Western Pacific, 2020;DOI：10.1016/j.lanwpc.2020.100016.
  12. Satta Yusuke, Yamashita Masaki, Matsuo Yasumasa, Kiyokawa Hirohumi, Sato Yoshinori, Takemura Hiromu, Kunishima Hiroyuki, Yasuda Hiroshi, Itoh Fumio. Non-tuberculous Mycobacterial Pseudo-outbreak of an Intestinal Culture Specimen Caused by a Water Tap in an Endoscopy Unit. Internal Medicine, 2020;59(22)：2811-2815.
  13. Daisuke Yoneoka, Shoi Shi, Shuhei Nomura, Yuta Tanoue, Takayuki Kawashima, Akifumi Eguchi, Kentaro Matsuura,Koji makiyama, Shinya Uryu, Keisuke Ejima, Haruka Sakamoto, Toshibumi Taniguchi, Hiroyuki Kunishima, Stuart Gilmour,Hiroshi Nishiura, Hiroaki Miyata. Assessing the regional impact of Japan's COVID-19 state of emergency declaration: a population-level observational study using social networking services. British Medical jounal, 2020;DOI：10.1136/bmjopen-2020-042002.
  14. Yamasaki Yukitaka, Ooka Seido, Tsuchida Tomoya, Nakamura Yuta, Hagiwara Yuta, Naitou Yoshiyuki, Ishibashi Yuki, Ikeda Hiroki, Sakurada Tsutomu, Handa Hiroshi, Nishine Hiroki, Takita Mumon, Morikawa Daiki, Yoshida Hideki, Fujii Shuichi, Morisawa Kenichiro, Takemura Hiromu, Fujitani Shigeki, Kunishima Hiroyuki. The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide. Virus Research, 2020;290：198089.
  15. Tomoya Tsuchida, Kenya Ie, Chiaki Okuse, Masanori Hirose, Hisashi Nishisako, Keito Torikai, Taku Tanaka, Hiroyuki Kunishima, Takahide Matsuda. Determining the factors affecting serum presepsin level and its diagnostic utility: A cross-sectional study. Journal of Infection and Chemotherapy, 2021;27：585-591.
  16. Tomoya Tsuchida, Yukitaka Yamasaki , Hiroyuki Kunishima , Kentaro Sato , Minoru Kanazawa, Asami Moriuchi , Daiki Morikawa, Mumon Takita, Yoshiyuki Naito , Shuichi Fujii, Shigeki Fujitani, Takahide Matsuda. Treatment of two cases of COVID-19 with ciclesonide resulted in amelioration of pneumonia symptoms. THE JAPANESE JOURNAL OF ANTIBIOTICS, 2020;73(2)：35-44.
  17. Tomoya Tsuchida, Yuko Nitahara, Shotaro Suzuki, Yuko Komase, Katherine Candray, asutoshi Kido, Yu Nakagama,Yukitaka Yamasaki, Mitsuru Imamura, Kimito Kawahata, Hiroyuki Kunishima, Shigeki Fujitani, Masamichi Mineshita, Takahide Matsuda. Back to Normal; Serological Testing for COVID-19 Diagnosis Unveils Missed Infections. Journal of Medical Virology, 2021;93(7)：4549-4552.
  18. Tomoya Tsuchida, Shigeki Fujitani, Yukitaka Yamasaki, Hiroyuki Kunishima, Takahide Matsuda. Development of a Protective Device for RT-PCR Testing SARS-CoV-2 in COVID-19 Patients . Infect Control Hosp Epidemiol, 2020;：1-2.
  19. Tomoya Tsuchida, Yukitaka Yamasaki, Masanori Hirose, Hiroyuki Kunishima, Shigeki Fujitani, Takahide Matsuda. A Hand Shield for Healthcare Workers -A Brief Report of New Type of Personal Protective Equipment. JOURNAL OF HOSPITAL GENERAL MEDICINE, 2021;3(1)：40-41.